- Home
- ANIX vs GCV Comparison
ANIX vs GCV Comparison
Compare ANIX & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- GCV
- Stock Information
- Founded
- ANIX 1982
- GCV 1988
- Country
- ANIX United States
- GCV United States
- Employees
- ANIX N/A
- GCV N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- GCV Finance/Investors Services
- Sector
- ANIX Health Care
- GCV Finance
- Exchange
- ANIX Nasdaq
- GCV Nasdaq
- Market Cap
- ANIX 91.7M
- GCV 76.3M
- IPO Year
- ANIX 1987
- GCV N/A
- Fundamental
- Price
- ANIX $2.59
- GCV $3.80
- Analyst Decision
- ANIX Strong Buy
- GCV
- Analyst Count
- ANIX 2
- GCV 0
- Target Price
- ANIX $8.50
- GCV N/A
- AVG Volume (30 Days)
- ANIX 101.3K
- GCV 57.9K
- Earning Date
- ANIX 01-14-2025
- GCV 01-01-0001
- Dividend Yield
- ANIX N/A
- GCV 13.04%
- EPS Growth
- ANIX N/A
- GCV N/A
- EPS
- ANIX N/A
- GCV N/A
- Revenue
- ANIX N/A
- GCV N/A
- Revenue This Year
- ANIX N/A
- GCV N/A
- Revenue Next Year
- ANIX N/A
- GCV N/A
- P/E Ratio
- ANIX N/A
- GCV N/A
- Revenue Growth
- ANIX N/A
- GCV N/A
- 52 Week Low
- ANIX $2.15
- GCV $3.15
- 52 Week High
- ANIX $5.13
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- ANIX 33.20
- GCV 40.12
- Support Level
- ANIX $2.80
- GCV $3.83
- Resistance Level
- ANIX $3.43
- GCV $4.14
- Average True Range (ATR)
- ANIX 0.18
- GCV 0.07
- MACD
- ANIX -0.04
- GCV -0.03
- Stochastic Oscillator
- ANIX 11.84
- GCV 3.23
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.